ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 106 filers reported holding ASCENDIS PHARMA A/S in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $258 | +1.2% | 2,754 | -3.8% | 0.00% | 0.0% |
Q2 2023 | $255 | -19.6% | 2,862 | -3.3% | 0.00% | 0.0% |
Q1 2023 | $317 | -14.8% | 2,959 | -3.0% | 0.00% | -33.3% |
Q4 2022 | $372 | -99.9% | 3,051 | +1.0% | 0.00% | 0.0% |
Q3 2022 | $312,000 | +8.3% | 3,022 | -2.5% | 0.00% | +50.0% |
Q2 2022 | $288,000 | -8.9% | 3,098 | +15.2% | 0.00% | 0.0% |
Q1 2022 | $316,000 | +1.0% | 2,689 | +15.9% | 0.00% | 0.0% |
Q4 2021 | $313,000 | -25.3% | 2,321 | -11.5% | 0.00% | -33.3% |
Q3 2021 | $419,000 | +44.5% | 2,623 | +19.3% | 0.00% | +50.0% |
Q2 2021 | $290,000 | -10.2% | 2,198 | -12.5% | 0.00% | 0.0% |
Q1 2021 | $323,000 | -25.6% | 2,512 | -3.5% | 0.00% | -33.3% |
Q4 2020 | $434,000 | +958.5% | 2,602 | +885.6% | 0.00% | – |
Q3 2020 | $41,000 | +41.4% | 264 | +1.9% | 0.00% | -100.0% |
Q2 2020 | $29,000 | 0.0% | 259 | 0.0% | 0.00% | – |
Q1 2020 | $29,000 | -19.4% | 259 | 0.0% | 0.00% | – |
Q4 2019 | $36,000 | +28.6% | 259 | -11.0% | 0.00% | – |
Q3 2019 | $28,000 | -15.2% | 291 | +2.5% | 0.00% | – |
Q2 2019 | $33,000 | +10.0% | 284 | +10.9% | 0.00% | – |
Q1 2019 | $30,000 | +76.5% | 256 | -7.6% | 0.00% | – |
Q4 2018 | $17,000 | +30.8% | 277 | +56.5% | 0.00% | – |
Q3 2018 | $13,000 | +8.3% | 177 | 0.0% | 0.00% | – |
Q2 2018 | $12,000 | 0.0% | 177 | 0.0% | 0.00% | – |
Q1 2018 | $12,000 | – | 177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |